We are sorry to announce that Lynkos will be shut off on 1st September. You can export your data by going to each section and selecting the export link in the options button on the right.
Sorry for the inconvenience and thank you for having been part of our story!

About Us

Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment approaces.

Business size

1-10 employees

Commercial presence